Interleukin-1 and the inflammasome as therapeutic targets in cardiovascular disease
The intracellular sensing protein termed NLRP3 (for NACHT, LRR, and PYD domains-
containing protein 3) forms a macromolecular structure called the NLRP3 inflammasome …
containing protein 3) forms a macromolecular structure called the NLRP3 inflammasome …
[HTML][HTML] Interleukin 1α: a comprehensive review on the role of IL-1α in the pathogenesis and treatment of autoimmune and inflammatory diseases
Abstract The interleukin (IL)-1 family member IL-1α is a ubiquitous and pivotal pro-
inflammatory cytokine. The IL-1α precursor is constitutively present in nearly all cell types in …
inflammatory cytokine. The IL-1α precursor is constitutively present in nearly all cell types in …
Acute pericarditis: update
E Lazarou, P Tsioufis, C Vlachopoulos… - Current Cardiology …, 2022 - Springer
Abstract Purpose of Review Since 2015, when ESC guidelines for the diagnosis and
management of pericardial diseases were published, ongoing research has enhanced the …
management of pericardial diseases were published, ongoing research has enhanced the …
Anti-inflammatory therapies for pericardial diseases in the COVID-19 pandemic: safety and potentiality
The COVID-19 pandemic is challenging our cardiovascular care of patients with heart
diseases. In the setting of pericardial diseases, there are two possible different scenarios to …
diseases. In the setting of pericardial diseases, there are two possible different scenarios to …
[HTML][HTML] The IL-1 cytokine family as custodians of barrier immunity
Abstract The interleukin-1 (IL-1) family of cytokines and receptors are implicated in the
functioning of innate and adaptive immunity and the genesis of inflammation. They are …
functioning of innate and adaptive immunity and the genesis of inflammation. They are …
Immunomodulating therapies in acute myocarditis and recurrent/acute pericarditis
The field of inflammatory disease of the heart or “cardio-immunology” is rapidly evolving due
to the wider use of non-invasive diagnostic tools able to detect and monitor myocardial …
to the wider use of non-invasive diagnostic tools able to detect and monitor myocardial …
The impact of cytokines in coronary atherosclerotic plaque: current therapeutic approaches
Coronary atherosclerosis is a chronic pathological process that involves inflammation
together with endothelial dysfunction and lipoprotein dysregulation. Experimental studies …
together with endothelial dysfunction and lipoprotein dysregulation. Experimental studies …
Anti-interleukin-1 agents for pericarditis: a primer for cardiologists
M Imazio, G Lazaros, M Gattorno… - European Heart …, 2022 - academic.oup.com
Abstract Anti-interleukin (IL)-1 agents have been developed for the treatment of
autoinflammatory and rheumatic conditions, where overproduction of IL-1 is an important …
autoinflammatory and rheumatic conditions, where overproduction of IL-1 is an important …
Treatment of idiopathic recurrent pericarditis with goflikicept: phase II/III study results
VY Myachikova, AL Maslyanskiy, OM Moiseeva… - Journal of the American …, 2023 - jacc.org
Background Idiopathic recurrent pericarditis (IRP) is a rare autoinflammatory disease.
Interleukin (IL)-1α and IL-1β are the pivotal cytokines in the pathophysiology of acute …
Interleukin (IL)-1α and IL-1β are the pivotal cytokines in the pathophysiology of acute …
Recent advances in pericarditis
E Bizzi, C Picchi, G Mastrangelo, M Imazio… - European Journal of …, 2022 - Elsevier
Pericardial diseases are an heterogeneous group of entities, ranging from acute pericarditis
to asymptomatic pericardial effusions. New advances in understanding the processes …
to asymptomatic pericardial effusions. New advances in understanding the processes …